Syndax Pharmaceuticals (SNDX) Treasury Shares (2015)

Syndax Pharmaceuticals' Treasury Shares history runs 7 years deep, the most recent figure standing at $2.6 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 100.72% year-over-year to $2.6 million; the TTM figure through Dec 2025 stood at $2.6 million (up 100.72% YoY), while the FY2025 annual figure was $2.6 million, up 100.72% from the prior year.
• Treasury Shares for Q4 2025 stood at $2.6 million, up from $1.3 million in the prior quarter.
• The five-year high for Treasury Shares was $2.6 million in Q4 2025, with the low at $132333.0 in Q4 2021.
• The 5-year median for Treasury Shares is $392288.0 (2023), against an average of $634897.7.
• The sharpest annual moves came in 2021 and 2023: Treasury Shares soared 615.31% in 2021, then surged 52.89% in 2023.
• Syndax Pharmaceuticals' Treasury Shares stood at $132333.0 in 2021, then jumped by 69.87% to $224788.0 in 2022, then soared by 131.08% to $519436.0 in 2023, then surged by 151.06% to $1.3 million in 2024, then surged by 100.72% to $2.6 million in 2025.
• Business Quant data shows SNDX's Treasury Shares at $2.6 million in Q4 2025, $1.3 million in Q4 2024, and $519436.0 in Q4 2023.